Schneid Yair 4/A
4/A · Galera Therapeutics, Inc. · Filed May 1, 2024
Insider Transaction Report
Form 4/AAmended
Schneid Yair
10% Owner
Transactions
- Purchase
Common Stock
2014-04-17$0.19/sh+318,150$60,449→ 8,361,353 total - Purchase
Common Stock
2024-04-17$0.20/sh+68,424$13,411→ 8,529,777 total - Purchase
Common Stock
2024-04-17$0.21/sh+50,000$10,600→ 8,877,705 total - Purchase
Common Stock
2024-04-17$0.22/sh+243,100$53,482→ 9,170,805 total - Purchase
Common Stock
2024-04-18$0.18/sh+17,211$3,184→ 10,193,221 total - Purchase
Common Stock
2024-04-18$0.20/sh+100,000$19,700→ 10,393,221 total - Purchase
Common Stock
2024-04-18$0.20/sh+4,342$868→ 10,649,408 total - Purchase
Common Stock
2024-04-18$0.20/sh+74,202$14,840→ 10,723,610 total - Purchase
Common Stock
2024-04-19$0.19/sh+314$59→ 10,724,024 total - Purchase
Common Stock
2024-04-19$0.19/sh+99,371$19,278→ 10,823,610 total - Purchase
Common Stock
2024-04-19$0.19/sh+215$40→ 10,724,239 total - Purchase
Common Stock
2024-04-17$0.21/sh+56,900$11,949→ 8,827,705 total - Purchase
Common Stock
2024-04-17$0.23/sh+551,217$126,780→ 9,722,022 total - Purchase
Common Stock
2024-04-18$0.19/sh+100,000$18,930→ 10,293,221 total - Purchase
Common Stock
2024-04-18$0.20/sh+4,245$848→ 10,645,066 total - Purchase
Common Stock
2024-04-17$0.20/sh+241,028$48,206→ 8,770,805 total - Purchase
Common Stock
2024-04-18$0.20/sh+247,600$49,025→ 10,640,821 total - Purchase
Common Stock
2024-04-17$0.19/sh+100,000$19,100→ 8,461,353 total - Purchase
Common Stock
2024-04-17$0.21/sh+50,000$10,700→ 8,927,705 total - Purchase
Common Stock
2024-04-17$0.24/sh+453,988$108,957→ 10,176,010 total - Purchase
Common Stock
2024-04-19$0.19/sh+100$19→ 10,723,710 total